Previous prospective trials of inhibitors or antibodies to gene products linked to sepsis, such as IL1RN, CD14, and tissue factor, failed to have benefit, suggesting that these genes are only a small part of a polygenic disease; blocking only this small part would have little overall effect [31–33]. Here, IL1RN is linked to Sepsis.